Syndromic Screening of Infectious Diseases

Instruments

Novodiag®

Is time to result critical for your samples of infectious diseases and antibiotic resistances? Is immediate detection necessary to reduce this time. Now you can have random access to Syndromic Screening of Infectious diseases.

More information

Amplidiag®

Are diagnostic tests for high-volume screening of gastrointestinal pathogens and antibiotic resistances.


More information

Novodiag®

Mobidiag provides rapid and sensitive on-demand results in a fully automated system. Now you can have random access to Syndromic Screening of Infectious diseases. We do have CE-IVD screening tests for most relevant bacteria responsible for diarrhea and clinically most relevant carbapenemases and colistin resistance.  Kits for stool parasites and Meningitis are in development.

Key Advantages

  • ‘Sample-in, result-out’ diagnostics system enabling syndromic testing
  • Results in about 1 hour with minimal hands-on time
  • Random access operation for on-demand testing
  • High and low-plex
  • qPCR and microarray technologies
  • Automated data analysis and reporting with LIS connectivity
  • Four independent slots per instrument for flexibility


Download the Novodiag brochure

Available test cartridges 

Novodiag® C. difficile
CE-IVD. For in vitro diagnostic use. With Novodiag® C. difficile, detect pathogenic Clostridium difficile in one single test. Screen for toxin B gene from Clostridium difficile in about an hour directly from stool samples with minimum hands on time.

Novodiag® Bacterial GE+
CE-IVD. For in vitro diagnostic use. With Novodiag® Bacterial GE+, detect enteric pathogens in one single test directly from stool sample. Screen for most relevant bacteria responsible for diarrhea in about an hour directly from stool samples. 

Novodiag® CarbaR+
CE-IVD. For in vitro diagnostic use. With Novodiag®CarbaR+, screen rapidly clinically most relevant carbapenemases and colistin resistance in one single test. 

Novodiag® Stool Parasites
CE-IVD stool parasite panel. Panel that covers >95% of intestinal parasites. This panel includes 25 target of Protozoa, Tapeworms, Flatworms, Roundworms, Microsporidia spp.

Under development

  • Meningitis
  • And more to come!


Download the Novodiag test panels flyer 

Amplidiag®

Amplidiag® are diagnostic tests for high-volume screening of gastrointestinal pathogens and antibiotic resistances. 
The Amplidiag® product family consists of the Amplidiag® Easy instrument and Amplidiag®test kits that can be used with the instrument or manually. Amplidiag® Easy automates the workflow from sample to final result.

Key Advantages

  • Automated processing of stool samples from primary tubes to PCR plate
  • Full workflow from sample to pipetted PCR plate for multiplex real-time PCR 
  • One platform for nearly all stool testing purposes
  • 48 samples in 2 hours
  • Well-suited for mid to high-volume processing of stool samples


Download the Amplidiag brochure

Available Amplidiag® test kits, based upon CE-IVD. For in vitro diagnostic use.

Amplidiag®H. pylori+ClariR
Reliable identification of Helicobacter pylori and clarithromycin resistance from stool samples and gastric biopsies.  Amplidiag®H. pylori+ClariR is a non-invasive qualitative multiplex real-time PCR test for reliably identifying both H. pylori and clarithromycin resistance directly from stool sample, DNA extract and gastric biopsies. To minimal the cross reactivity related species Mobidiag uses the novel PCR method to detect H. pylori and its clarithromycin resistance within the same specific PCR product.

Amplidiag® Bacterial GE
Reliable and robust qualitative multiplex real-time PCR in vitro diagnostic screening test for bacterial pathogens from stool samples without pre-culturing. Separation of Stx genes allow focusing clinical and laboratory effort to cases that require special attention. The Amplidiag® Bacterial GE has target gene identification to EHEC. 

Amplidiag® CarbaR+VRE
Amplidiag® CarbaR+VRE identifies clinically most relevant carbapenemase groups as well as vancomycin resistance markers in one single test. This molecular diagnostic test is a cost-effective solution for high-volume screening from stool samples, rectal swabs or pure culture samples for the diagnosis of carbapenemase-producing organisms (CPO) and vancomycin-resistant Enterococci (VRE). This qualitative multiplex real-time PCR test gives results within a few hours, as opposed to days with culture-based screening methods. It supports decisions to manage efficiently epidemiological and infection control measures and improve patient care.

Amplidiag® CarbaR+MCR
Amplidiag® CarbaR+MCR identifies clinically most relevant carbapenemase groups as well as colistin resistance markers in one single test directly from stool, rectal swabs and pure culture samples.This qualitative multiplex real-time PCR test gives results within a few hours, as opposed to days with culture-based screening methods. By allowing rapid and reliable detection of antibiotic resistances, Amplidiag CarbaR+MCR supports decisions to manage efficiently epidemiological and infection control measures and improve patient care.

Amplidiag® Stool Parasites
Amplidiag® Stool Parasites identifies the four most frequent parasites rapidly from a single stool sample in a single reaction. This qualitative multiplex real-time PCR test is used as the  screening method for stools incoming for parasite analysis. The current screening method, microscopy, can have errors and requires expertise. Amplidiag Stool Parasites allows effective detection of Cryptosporidium spp., Giardia lamblia, Entamoeba histolytica and Dientamoeba fragilis..

Amplidiag® Viral GE
Amplidiag® Viral GE identifies the five clinically most important enteric viruses rapidly from a single stool sample, and the test covers all clinically relevant subgroups. The sample material is total nucleic acid extracted from a stool sample. While rotavirus, astrovirus, and adenovirus are the predominant causes of gastroenteritis in children less than five years old, norovirus and sapovirus cause diarrhea in patients of all ages. With this test you screen relevant viral pathogens at once, without parallel or subsequent testing.

Amplidiag® C. difficile+027
With the Amplidiag® C. difficile+027 it is now possible to identify toxin B gene in C. difficile and its 027 ribotype directly from stool sample. In a single qualitative multiplex real-time PCR it is possible to differentiates the hypervirulent 027 ribotype and non-027 ribotypes. 

Download the Amplidiag test panels overview 
 

LEARN MORE ABOUT THE MOBIDIAG SOLUTIONS

Request a quote or ask your question about the Novodiag of Amplidiag via the contact options below. We will try to answer your question within one working day.

CONTACTFORM

Direct contact

+31 30 6880771
info@isogen-lifescience.com

OUR OFFICE

Veldzigt 2A
3454 PW De Meern

BUSINESS HOURS

Mo - Fri: 8.30 - 17.00